My watch list  

33 Current news about the topic medical diagnostics


You can refine your search further. Select from the filter options on the left to narrow down your results.

Amersham plc appoints Peter Loescher as Chief Operating Officer


Amersham plc announced the appointment of Peter Loescher to the role of Chief Operating Officer, effective 1 January 2004. Mr Loescher, 46, joined the company in December 2002 as President of Amersham Health and an Executive member of the Amersham plc Board. In this new role Mr Loescher will ...


Amersham Licenses Early-Stage Alzheimer's Disease PET Agents from University of Pittsburgh


Amersham, a leader in medical diagnostics and in life sciences, announced the in-licensing of a class of molecules from the University of Pittsburgh targeting amyloid plaque in the brain. Amersham's strategy is to identify a lead candidate for clinical evaluation as a PET (Positron Emission ...


Lilly Complements its Drug Discovery Research with Integrated Cellular Screening System from Amersham Biosciences


Amersham, a world leader in medical diagnostics and in life sciences, announces that Eli Lilly and Company has purchased an integrated suite of cellular screening technology and licenses to help in the identification of potential therapeutics in its drug discovery program. In addition to the ...


Page 4 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE